RNAC (Cartesian Therapeutics) Tax Rate %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RNAC Cartesian Therapeutics Inc RNAC
24 GF Score
Price $10.88
GF Value $0.29
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cartesian Therapeutics Tax Rate %?

Cartesian Therapeutics RNAC +8.10% 24 Tax Rate % is 0.00% as of Jun. 2026. GuruFocus rates RNAC with a GF Score™ of 24/100 and a GF Value™ of $0.29 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Cartesian Therapeutics's Tax Expense for the three months ended in Jun. 2026 was $0.00 Mil. Cartesian Therapeutics's Pre-Tax Income for the three months ended in Jun. 2026 was $15.77 Mil. Therefore, Cartesian Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 was 0.00%.

Cartesian Therapeutics Tax Rate % Related Terms

Cartesian Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Cartesian Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cartesian Therapeutics Tax Rate % Chart

Cartesian Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -164.24 -1.75 7.96 -0.37 6.59

Cartesian Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RNAC
24GF Score
Cartesian Therapeutics Inc RNAC
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cartesian Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Cartesian Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-9.193/-139.495
=6.59 %

Cartesian Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=0/15.769
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.00% mean?
Cartesian Therapeutics (RNAC) has a Tax Rate % of 0.00% as of Jun. 2026.
Is Cartesian Therapeutics' Tax Rate % too high?
Cartesian Therapeutics' current Tax Rate % is 0.00%. Overall, Cartesian Therapeutics has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cartesian Therapeutics' Tax Rate % compare to CNXU and GALT?
Cartesian Therapeutics' Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Cartesian Therapeutics's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cartesian Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Cartesian Therapeutics (RNAC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.29, compared to a current price of $10.88 — trading 3651.7% above its estimated fair value. The current Tax Rate % is 0.00%. Cartesian Therapeutics' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Cartesian Therapeutics (RNAC), the current Tax Rate % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cartesian Therapeutics (RNAC) Overvalued in 2026?

Based on GuruFocus' analysis, Cartesian Therapeutics stock appears to be overvalued. The current stock price of $10.88 is trading 3651.7% above its estimated GF Value™ of $0.29. GuruFocus considers Cartesian Therapeutics to be Significantly Overvalued.

Key valuation signals for RNAC:

  • Tax Rate %: 0.00%
  • GF Value™: $0.29 vs. price of $10.88 (3651.7% above fair value)
  • GF Score™: 24/100 with 5 warning signs

No single metric tells the full story. See the RNAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cartesian Therapeutics Business Description

Other Exchanges 1S70:Germany
Address 7495 New Horizon Way, Frederick, MD, USA, 21703
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
24GF Score

Get the complete analysis for RNAC

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.88
Price
$0.29
GF Value